Rapid Nitric Oxide-induced Desensitization of the CGMP Response is Caused by Increased Activity of Phosphodiesterase Type 5 Paralleled by Phosphorylation of the Enzyme

Overview

Journal J Cell Biol

Specialty Cell Biology

Date 2001 Oct 18

PMID 11604422

Citations 43

Authors

F Mullershausen

M Russwurm

W J Thompson

L Liu

D Koesling

A Friebe

Affiliations

Soon will be listed here.

Abstract

Most of the effects of the signaling molecule nitric oxide (NO) are mediated by cGMP, which is synthesized by soluble guanylyl cyclase and degraded by phosphodiesterases. Here we show that in platelets and aortic tissue, NO led to a biphasic response characterized by a tremendous increase in cGMP (up to 100-fold) in less than 30 s and a rapid decline, reflecting the tightly controlled balance of guanylyl cyclase and phosphodiesterase activities. Inverse to the reported increase in sensitivity caused by NO shortage, concentrating NO attenuated the cGMP response in a concentration-dependent manner. We found that guanylyl cyclase remained fully activated during the entire course of the cGMP response; thus, desensitization was not due to a switched off guanylyl cyclase. However, when intact platelets were incubated with NO and then lysed, enhanced activity of phosphodiesterase type 5 was detected in the cytosol. Furthermore, this increase in cGMP degradation is paralleled by the phosphorylation of phosphodiesterase type 5 at Ser-92. Thus, our data suggest that NO-induced desensitization of the cGMP response is caused by the phosphorylation and subsequent activity increase of phosphodiesterase type 5.

Citing Articles

Thiol-catalyzed formation of NO-ferroheme regulates intravascular NO signaling.

DeMartino A, Poudel L, Dent M, Chen X, Xu Q, Gladwin B Nat Chem Biol. 2023; 19(10):1256-1266.

PMID: 37710075 PMC: 10897909. DOI: 10.1038/s41589-023-01413-3.

Association of ADP-Induced Whole-Blood Platelet Aggregation with Serum Low-Density Lipoprotein Cholesterol in Patients with Coronary Artery Disease When Receiving Maintenance Ticagrelor-Based Dual Antiplatelet Therapy.

Chyrchel B, Kruszelnicka O, Wieczorek-Surdacka E, Surdacki A J Clin Med. 2023; 12(13).

PMID: 37445565 PMC: 10342583. DOI: 10.3390/jcm12134530.

Current concepts and novel targets for antiplatelet therapy.

Gawaz M, Geisler T, Borst O Nat Rev Cardiol. 2023; 20(9):583-599.

PMID: 37016032 DOI: 10.1038/s41569-023-00854-6.

The Role of NO/sGC/cGMP/PKG Signaling Pathway in Regulation of Platelet Function.

Gambaryan S Cells. 2022; 11(22).

PMID: 36429131 PMC: 9688146. DOI: 10.3390/cells11223704.

Multidrug-resistant protein inhibitor and phosphodiesterase inhibitor potentiate the vasodilator effect induced by photobiomodulation in isolated aortic rings.

de Moraes L, Terroni B, da Silva Mayer N, Rodrigues G Lasers Med Sci. 2021; 37(2):1209-1216.

PMID: 34313892 DOI: 10.1007/s10103-021-03374-2.

References

Ignarro L, Cirino G, Casini A, Napoli C . Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharmacol. 1999; 34(6):879-86. DOI: 10.1097/00005344-199912000-00016. View

Biel M, Zong X, Ludwig A, Sautter A, Hofmann F . Structure and function of cyclic nucleotide-gated channels. Rev Physiol Biochem Pharmacol. 1999; 135:151-71. DOI: 10.1007/BFb0033672. View

Bellamy T, Wood J, Goodwin D, Garthwaite J . Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses. Proc Natl Acad Sci U S A. 2000; 97(6):2928-33. PMC: 16032. DOI: 10.1073/pnas.97.6.2928. View

Hofmann F, Ammendola A, Schlossmann J . Rising behind NO: cGMP-dependent protein kinases. J Cell Sci. 2000; 113 ( Pt 10):1671-6. DOI: 10.1242/jcs.113.10.1671. View

Corbin J, Turko I, Beasley A, Francis S . Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities. Eur J Biochem. 2000; 267(9):2760-7. DOI: 10.1046/j.1432-1327.2000.01297.x. View

Rothermund L, Friebe A, Paul M, Koesling D, Kreutz R . Acute blood pressure effects of YC-1-induced activation of soluble guanylyl cyclase in normotensive and hypertensive rats. Br J Pharmacol. 2000; 130(2):205-8. PMC: 1572080. DOI: 10.1038/sj.bjp.0703320. View

Francis S, Turko I, Corbin J . Cyclic nucleotide phosphodiesterases: relating structure and function. Prog Nucleic Acid Res Mol Biol. 2000; 65:1-52. DOI: 10.1016/s0079-6603(00)65001-8. View

Liu L, Underwood T, Li H, Pamukcu R, Thompson W . Specific cGMP binding by the cGMP binding domains of cGMP-binding cGMP specific phosphodiesterase. Cell Signal. 2001; 14(1):45-51. DOI: 10.1016/s0898-6568(01)00216-9. View

Corash L, Tan H, Gralnick H . Heterogeneity of human whole blood platelet subpopulations. I. Relationship between buoyant density, cell volume, and ultrastructure. Blood. 1977; 49(1):71-87. View

10.

Waldman S, Rapoport R, Ginsburg R, Murad F . Desensitization to nitroglycerin in vascular smooth muscle from rat and human. Biochem Pharmacol. 1986; 35(20):3525-31. DOI: 10.1016/0006-2952(86)90622-2. View

11.

Waldman S, Murad F . Cyclic GMP synthesis and function. Pharmacol Rev. 1987; 39(3):163-96. View

12.

Schroder H, Leitman D, Bennett B, Waldman S, Murad F . Glyceryl trinitrate-induced desensitization of guanylate cyclase in cultured rat lung fibroblasts. J Pharmacol Exp Ther. 1988; 245(2):413-8. View

13.

Moncada S, Rees D, Schulz R, Palmer R . Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci U S A. 1991; 88(6):2166-70. PMC: 51190. DOI: 10.1073/pnas.88.6.2166. View

14.

Eigenthaler M, Nolte C, Halbrugge M, Walter U . Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells. Eur J Biochem. 1992; 205(2):471-81. DOI: 10.1111/j.1432-1033.1992.tb16803.x. View

15.

Ujiie K, Hogarth L, DANZIGER R, Drewett J, Yuen P, Pang I . Homologous and heterologous desensitization of a guanylyl cyclase-linked nitric oxide receptor in cultured rat medullary interstitial cells. J Pharmacol Exp Ther. 1994; 270(2):761-7. View

16.

Traut T . Physiological concentrations of purines and pyrimidines. Mol Cell Biochem. 1994; 140(1):1-22. DOI: 10.1007/BF00928361. View

17.

Garthwaite J, Boulton C . Nitric oxide signaling in the central nervous system. Annu Rev Physiol. 1995; 57:683-706. DOI: 10.1146/annurev.ph.57.030195.003343. View

18.

Friebe A, Schultz G, Koesling D . Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. EMBO J. 1996; 15(24):6863-8. PMC: 452512. View

19.

Filippov G, Bloch D, Bloch K . Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells. J Clin Invest. 1997; 100(4):942-8. PMC: 508267. DOI: 10.1172/JCI119610. View

20.

Wyatt T, Naftilan A, Francis S, Corbin J . ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells. Am J Physiol. 1998; 274(2):H448-55. DOI: 10.1152/ajpheart.1998.274.2.H448. View